Skip to content

Dortmund, 1st April 2022

Bei Kaja Reifferts Forschung spielen Bakterien wie Escherichia coli (E. coli) eine wichtige Rolle. Die Nachwuchswissenschaftlerin beobachtet unter anderem die Entwicklung der von ihr kultivierten und behandelten Bakterienstämme.
© ISAS

Bacteria such as Escherichia coli (E. coli) play an important role in Kaja Reiffert’s research. The young scientist monitors the development of the bacterial strains she has cultivated and treated.

Kaja Reiffert (24) is a doctoral student in the Bioimaging working group. In her dissertation, she studies the effects of ultra-small silver nanoparticles on the human body. In order to learn more about her work in the lab, the editorial team asked Kaja to finish the following sentences.

  • At ISAS I am working on…

    investigating the influence of ultra-small metallic nanoparticles (1-2 nm small) on eukaryotic and prokaryotic cells. Eurkaryotes are, for example, fungi, animals or plants. Bacteria are prokaryotes.

  • This research question is important because…

    nanoparticles could potentially prevent bacterial infection in connection with implants in the clinic.

  • My theory is…

    that ultra-small silver nanoparticles show an enhanced antimicrobial effect, but also cytotoxic activity. This means there is a chance that they kill bacteria, but damage our cells at the same time. I want to find out whether I can modulate this ‘toxic’ activity through a combination of different metals and thus adjust it to eukaryotic and prokaryotic cells.

  • The equipment I use most in the lab is…

    the confocal microscope for my analysis of fluorescence-marked nanoparticles.

  • My experiments are…

    amongst others, so-called vitality assays, the cultivation of eukaryotic and prokaryotic cells as well as analyses with microscopes and a flow cytometer. I am always planning new experiments.

  • My highlight every day is…

    to be able to look back on a productive and eventful day.

Kaja Reiffert is doing her PhD at the University of Duisburg-Essen. The title of her dissertation is "Ultra-small Mono- and Bi-metallic Nanoparticles as a Possible Prevention Strategy of Implant-associated Infections" (Ultrakleine mono- und bimetallische Nanopartikel als mögliche Präventionsstrategie Implantat-assoziierter Infektionen). Her work contributes to the research project "Synthesis, structure, and biological effects of ultrasmall (1-2 nm) bimetallic silver-platinum nanoparticles". The German Research Association (DFG) funds the project under the number 452179459.

Share

Further articles

8th September 2025

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.
8th September 2025

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

23rd July 2025

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.
8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.